These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19302936)

  • 1. Newborn screening for Krabbe disease: a model of cooperation.
    Howell RR
    Pediatr Neurol; 2009 Apr; 40(4):256-7. PubMed ID: 19302936
    [No Abstract]   [Full Text] [Related]  

  • 2. Newborn screening for Krabbe disease: the New York State model.
    Duffner PK; Caggana M; Orsini JJ; Wenger DA; Patterson MC; Crosley CJ; Kurtzberg J; Arnold GL; Escolar ML; Adams DJ; Andriola MR; Aron AM; Ciafaloni E; Djukic A; Erbe RW; Galvin-Parton P; Helton LE; Kolodny EH; Kosofsky BE; Kronn DF; Kwon JM; Levy PA; Miller-Horn J; Naidich TP; Pellegrino JE; Provenzale JM; Rothman SJ; Wasserstein MP
    Pediatr Neurol; 2009 Apr; 40(4):245-52; discussion 253-5. PubMed ID: 19302934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parents: critical stakeholders in expanding newborn screening.
    Ross LF; Waggoner DJ
    J Pediatr; 2012 Sep; 161(3):385-9. PubMed ID: 22727864
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementation of newborn screening for Krabbe disease: population study and cutoff determination.
    Orsini JJ; Morrissey MA; Slavin LN; Wojcik M; Biski C; Martin M; Keutzer J; Zhang XK; Chuang WL; Elbin C; Caggana M
    Clin Biochem; 2009 Jun; 42(9):877-84. PubMed ID: 19318021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model in response to newborn screening mandates.
    Duffner PK
    Pediatr Neurol; 2009 Aug; 41(2):156. PubMed ID: 19589470
    [No Abstract]   [Full Text] [Related]  

  • 6. Weighing the evidence for newborn screening for early-infantile Krabbe disease.
    Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM
    Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Krabbe Disease and Identification of Minority Patients.
    Bonkowsky JL; Wilkes J; Baker M; Grantham A; Kurtzberg J; Orsini J
    Pediatr Neurol; 2024 Feb; 151():65-67. PubMed ID: 38103524
    [No Abstract]   [Full Text] [Related]  

  • 8. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.
    Kwon JM; Matern D; Kurtzberg J; Wrabetz L; Gelb MH; Wenger DA; Ficicioglu C; Waldman AT; Burton BK; Hopkins PV; Orsini JJ
    Orphanet J Rare Dis; 2018 Feb; 13(1):30. PubMed ID: 29391017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease.
    Li Y; Brockmann K; Turecek F; Scott CR; Gelb MH
    Clin Chem; 2004 Mar; 50(3):638-40. PubMed ID: 14981030
    [No Abstract]   [Full Text] [Related]  

  • 10. Dangerous and expensive screening and treatment for rare childhood diseases: the case of Krabbe disease.
    Lantos JD
    Dev Disabil Res Rev; 2011; 17(1):15-8. PubMed ID: 22447750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards.
    Puckett RL; Orsini JJ; Pastores GM; Wang RY; Chang R; Saavedra-Matiz CA; Torres PA; Zeng B; Caggana M; Lorey F; Abdenur JE
    Mol Genet Metab; 2012 Jan; 105(1):126-31. PubMed ID: 22115770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State.
    Wasserstein MP; Andriola M; Arnold G; Aron A; Duffner P; Erbe RW; Escolar ML; Estrella L; Galvin-Parton P; Iglesias A; Kay DM; Kronn DF; Kurtzberg J; Kwon JM; Langan TJ; Levy PA; Naidich TP; Orsini JJ; Pellegrino JE; Provenzale JM; Wenger DA; Caggana M
    Genet Med; 2016 Dec; 18(12):1235-1243. PubMed ID: 27171547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perils of newborn screening: doctors may be testing infants for too many diseases.
    Bleicher A
    Sci Am; 2012 Jul; 307(1):30-1. PubMed ID: 22779267
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.
    Ross LF
    Pediatr Clin North Am; 2015 Jun; 62(3):787-98. PubMed ID: 26022175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making Decisions About Krabbe Disease Newborn Screening.
    Kurtzberg J; Matern D; Orsini JJ; Gelb M; Pike-Langenfeld S; Brackbill L; Grantham A; Steyermark AC
    Pediatrics; 2022 Aug; 150(2):. PubMed ID: 35896799
    [No Abstract]   [Full Text] [Related]  

  • 16. Making Decisions About Krabbe Disease Newborn Screening.
    Schrier Vergano SA; Kanungo S; Arnold G
    Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35229104
    [No Abstract]   [Full Text] [Related]  

  • 17. Infantile Krabbe disease.
    Korn-Lubetzki I; Nevo Y
    Arch Neurol; 2003 Nov; 60(11):1643-4. PubMed ID: 14623741
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening: Baby's first test.
    Gupta S
    Nature; 2016 Sep; 537(7621):S162-4. PubMed ID: 27652786
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical issues with testing and treatment for Krabbe disease.
    Ehmann P; Lantos JD
    Dev Med Child Neurol; 2019 Dec; 61(12):1358-1361. PubMed ID: 31090922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why must the debate continue on Krabbe disease newborn screening?
    Pike-Langenfeld S
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):153-155. PubMed ID: 36056676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.